Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Innate T-cells as a Biomarker of Successful TKI Arrest in Chronic Myeloid Leukemia

NCT04645706 is registered in ClinicalTrials.gov with Poitiers University Hospital as lead sponsor.

NCT NCT04645706
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04645706 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Innate T-cells as a Biomarker of Successful TKI Arrest in Chronic Myeloid Leukemia
Lead sponsor
Poitiers University Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
April 20, 2021
Completion date
April 30, 2028
Enrollment
92 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myeloid leukemia